TMDX

Q: What is the price of TransMedics Group (TMDX) today?

The price of TransMedics Group (TMDX) today is R$ 624,28, with a variation of -32.31% compared to the last year. The price of TransMedics Group (TMDX) started the year trading around R$ 337,94 and today it is at R$ 624,28. Follow the real-time price chart, the historical price of TransMedics Group (TMDX), and stock data from Ibovespa and international markets.

Q: When does TransMedics Group (TMDX) pay dividends?

TransMedics Group (TMDX) did not distribute dividends in the last year.

Q: TransMedics Group (TMDX) is it worth it?

Currently, TransMedics Group (TMDX) is priced at R$ 624,28, with a P/E of 56,86%, representing a deviation of -10,59% from its historical average P/E. In the last year, the stock showed a variation of -32.31% in its price and distributed R$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was -32,31%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How to buy shares of TransMedics Group (TMDX)?

Investing in shares of TransMedics Group (TMDX) can be done in two ways: by buying the stock abroad or the BDR in Brazil (if available). The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.The BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much do 100 shares of TransMedics Group (TMDX) yield today?

The yield of TransMedics Group (TMDX) was 6,53% in the last month, -32,31% in the last year and 0,00% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of R$ 0,00 in dividends, um Dividend Yield de 0,00%.If you wanted to buy 100 shares of TransMedics Group (TMDX) today, the total investment would be based on the current price of R$ 624,28.If past performance were to repeat, the return on your investment would be:In 1 year: R$ 42.257,22In 5 years: R$ 62.427,56In 10 years: 62.427,56It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

TransMedics Group Inc.

Price

US$ 115,18

variation (12m)

-32,31%

p/l

56,86

p/vp

12,81

DIVIDEND YIELD

0,00%

quote TMDX

BVMF

TMDX

If you had invested

year ago

6 months

1 year

5 years

10 years

today you would have

today you would have:

*The figure considers the reinvestment of dividends.

profitability of TMDX

1 month

3 months

1 year

2 years

5 years

10 years

profitability

1 month

6,53%

3 months

-10,45%

1 year

-32,31%

2 years

84,26%

5 years

0,00%

10 years

0,00%

real profitability

profitability minus inflation.

1 month

6,53%

3 months

-10,90%

1 year

-35,68%

2 years

67,96%

5 years

0,00%

10 years

0,00%

Indicators TMDX

check out the fundamentals of TransMedics Group shares

P/L

56,86

Sector: -1,52 Industry: -3,80

P/SALES (PSR)

7,67

Sector: 1,99 Industry: 2,90

P/VP

12,81

Sector: 2,16 Industry: 1,76

DIVIDEND YIELD (DY)

0,00%

Sector: - Industry: -

ROA

8,05%

Sector: -26,53% Industry: -56,94%

ROE

22,53%

Sector: -31,21% Industry: -45,34%

ROIC

30,86%

Sector: -404,40% Industry: -420,46%

Net Margin

13,49%

Sector: -26,56% Industry: -32,35%

GROSS MARGIN

59,79%

Sector: 44,49% Industry: 44,86%

OPERATING MARGIN

14,41%

Sector: -23,10% Industry: -30,21%

P/EBITDA

36,40

Sector: 0,07 Industry: -2,60

P/EBIT

46,19

Sector: -1,37 Industry: -3,22

P/ASSETS

4,58

Sector: 1,23 Industry: 1,32

VPA

9,36

Sector: 3,66 Industry: 1,68

LPA

2,11

Sector: -0,80 Industry: -1,22

EQUITY / ASSETS

0,36

Sector: 0,45 Industry: 0,48

CAGR REVENUES 5 YEARS

83,35%

Sector: - Industry: -

CAGR PROFITS 5 YEARS

0,00%

Sector: - Industry: -

FAIR PRICE OF TransMedics Group ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Price

The Fair Price formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

US$ 115,18

Fair Price

US$ 0,00

Upside Potencial de rentabilidade.

-81,70%

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

TMDX indicators history

DRAG THE FRAME TO SEE MORE DATA

comparator of Stocks

DRAG THE FRAME TO SEE MORE DATA

	p/l	p/vp	ROE	dy	market value	Net Margin
LLY	45,25	34,03	75,21%	0,81%	US$ 624,41 B	25,91%
ISRG	65,56	9,52	14,52%	0,00%	US$ 170,94 B	28,51%
TMO	28,71	3,73	13,01%	0,33%	US$ 189,00 B	15,24%
MDT	25,50	0,00	0,00%	3,03%	US$ 118,85 B	13,63%
SNY	11,17	1,55	13,90%	4,31%	US$ 125,86 B	14,83%
CVS	19,92	1,16	5,84%	3,73%	US$ 90,27 B	1,17%
GSK	17,94	4,15	23,12%	4,04%	US$ 80,77 B	10,87%
ABT	15,66	4,31	27,50%	1,81%	US$ 218,97 B	32,43%
NVS	18,12	5,88	32,47%	3,05%	US$ 247,36 B	24,74%
HCA	16,35	-78,84	-482,31%	0,68%	US$ 97,60 B	8,21%
BSX	62,73	6,94	11,06%	0,00%	US$ 157,13 B	13,54%
INMD	5,22	1,48	28,44%	0,00%	US$ 933,03 M	44,50%
DHR	44,49	2,90	6,52%	0,56%	US$ 151,86 B	14,21%
IDXX	52,40	35,40	67,57%	0,00%	US$ 51,64 B	24,41%
FMS	20,59	0,91	4,42%	3,07%	US$ 15,03 B	3,41%
HUM	23,00	1,98	8,61%	1,18%	US$ 36,24 B	1,28%
PHG	127,59	2,23	1,75%	3,13%	US$ 26,81 B	1,07%
DXCM	56,42	12,53	22,21%	0,00%	US$ 32,25 B	13,29%
RMD	30,62	7,19	23,47%	0,72%	US$ 42,88 B	27,22%

comparison of TMDX with indexes

If you had invested (change) 2 years a year ago, today you would have

R$ 1.000,00 in PETR4 you would have R$ 2.294,60

R$ 1.000,00 in LEVE3 you would have R$ 5.240,60

*The value considers the reinvestment of dividends.

dividend history TMDX dividend history

Current DY: 0,00%

5-year average DY: 0,00%

no dividend paid in the period.

ABOUT THE COMPANY TransMedics Group

TransMedics Group Inc.

Average user rating I10

4.0 (30 people)

Estados Unidos

7 years

Foundation: 2018

2019

Year of debut on the stock exchange - 6 years

110

Employees

The Company TransMedics Group Inc. (Estados Unidos), is listed on Nasdaq with a market value of $ 4,07 Billions, having a net worth of $ 318,10 Milhões.

With a total of 110 employees, the company is listed in the sector of Saúde and categorized in industry of Materiais e Equipamentos Médicos.

In the last 12 months the Company had a revenue of $ 531,29 Milhões, which generated a profit in the amount of $ 71,67 Milhões.

As for its main indicators, the Company has a P/E ratio of 56,86, a P/B ratio of 12,81 and in the last 12 months the Company did not pay dividends.

The Company is traded through the ticker TMDX.

Market value

US$ 4,07 Billions

Net worth

US$ 318,10 Milhões

US$ 318.100.000,00

Assets

US$ 890,52 Milhões

US$ 890.520.000,00

Total Number of Shares

34,00 Milhões

34.000.000

Average Daily Trading Volume

US$ 1,06 Million

US$ 1.063.900,64

Sector

Saúde

Industry

Materiais e Equipamentos Médicos

TMDX

TMDX revenue and profits

TMDX results

DRAG THE FRAME TO SEE MORE DATA

TMDX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

LBPSW - 4D pharma

US$ - -0,00% (12M)

P/L

0,00

0,00%

ROE

-300,00%

P/VP

0,00

CVS - CVS Health

US$ 71,55 30,23% (12M)

P/L

19,92

3,73%

ROE

5,84%

P/VP

1,16

CI - Cigna

US$ 300,32 --13,19% (12M)

P/L

16,13

1,91%

ROE

12,41%

P/VP

2,00

CNC - Centene

US$ 28,66 --63,26% (12M)

P/L

7,07

0,00%

ROE

7,47%

P/VP

0,53

HUM - Humana

US$ 298,87 --14,32% (12M)

P/L

23,00

1,18%

ROE

8,61%

P/VP

1,98

SNY - Sanofi

US$ 50,30 --6,73% (12M)

P/L

11,17

4,31%

ROE

13,90%

P/VP

1,55

HCA - HCA Healthcare

US$ 401,96 4,05% (12M)

P/L

16,35

0,68%

ROE

-482,31%

P/VP

-78,84

LLY - Eli Lilly

US$ 736,03 --22,19% (12M)

P/L

45,25

0,81%

ROE

75,21%

P/VP

34,03

LBPSW - 4D pharma

US$ - -0,00% (12 M)

P/L

0,00

0,00%

ROE

-300,00%

P/VP

0,00

CVS - CVS Health

US$ 71,55 30,23% (12 M)

P/L

19,92

3,73%

ROE

5,84%

P/VP

1,16

CI - Cigna

US$ 300,32 --13,19% (12 M)

P/L

16,13

1,91%

ROE

12,41%

P/VP

2,00

CNC - Centene

US$ 28,66 --63,26% (12 M)

P/L

7,07

0,00%

ROE

7,47%

P/VP

0,53

HUM - Humana

US$ 298,87 --14,32% (12 M)

P/L

23,00

1,18%

ROE

8,61%

P/VP

1,98

SNY - Sanofi

US$ 50,30 --6,73% (12 M)

P/L

11,17

4,31%

ROE

13,90%

P/VP

1,55

HCA - HCA Healthcare

US$ 401,96 4,05% (12 M)

P/L

16,35

0,68%

ROE

-482,31%

P/VP

-78,84

LLY - Eli Lilly

US$ 736,03 --22,19% (12 M)

P/L

45,25

0,81%

ROE

75,21%

P/VP

34,03

Common Questions

What is the price of TransMedics Group (TMDX) today?

The price of TransMedics Group (TMDX) today is R$ 624,28, with a variation of -32.31% compared to the last year. The price of TransMedics Group (TMDX) started the year trading around R$ 337,94 and today it is at R$ 624,28. Follow the real-time price chart, the historical price of TransMedics Group (TMDX), and stock data from Ibovespa and international markets.

When does TransMedics Group (TMDX) pay dividends?

TransMedics Group (TMDX) did not distribute dividends in the last year.

TransMedics Group (TMDX) is it worth it?

Currently, TransMedics Group (TMDX) is priced at R$ 624,28, with a P/E of 56,86%, representing a deviation of -10,59% from its historical average P/E. In the last year, the stock showed a variation of -32.31% in its price and distributed R$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was -32,31%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How to buy shares of TransMedics Group (TMDX)?

Investing in shares of TransMedics Group (TMDX) can be done in two ways: by buying the stock abroad or the BDR in Brazil (if available). The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

The BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much do 100 shares of TransMedics Group (TMDX) yield today?

The yield of TransMedics Group (TMDX) was 6,53% in the last month, -32,31% in the last year and 0,00% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of R$ 0,00 in dividends, um Dividend Yield de 0,00%.

If you wanted to buy 100 shares of TransMedics Group (TMDX) today, the total investment would be based on the current price of R$ 624,28.

If past performance were to repeat, the return on your investment would be:

In 1 year: R$ 42.257,22
In 5 years: R$ 62.427,56
In 10 years: 62.427,56

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

TMDX

TransMedics Group Inc.

Price

variation (12m)

p/l

p/vp

DIVIDEND YIELD

profitability of TMDX

check out the fundamentals of TransMedics Group shares

P/L

P/SALES (PSR)

P/VP

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

Net Margin

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSETS

VPA

LPA

EQUITY / ASSETS

CAGR REVENUES 5 YEARS

CAGR PROFITS 5 YEARS

Graham's Fair Price

If you had invested (change) 2 years a year ago, today you would have

Current DY: 0,00%

5-year average DY: 0,00%

ABOUT THE COMPANY TransMedics Group

TransMedics Group Inc.

Estados Unidos

7 years

2019

110

PROFIT X PRICE TMDX

TMDX results

TMDX cash flow

evolution of assets - TMDX

TMDX balance sheet

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

HCA - HCA Healthcare

LLY - Eli Lilly

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

HCA - HCA Healthcare

LLY - Eli Lilly

Common Questions

Tudo que o investidor precisa em um só lugar

Pague 2, Leve 3

Anual

Valor total R$ 238,80